Identifying risk factors associated with metastatic progression from non-metastatic primary lung cancer among NLST lung cancer patients
• Characterize lung cancer patients with distant metastatic progression vs. not in the duration of the NLST between 2002 and 2009 (for various metastatic sites)
• Elucidate risk factors and building predictive model of various metastatic sites in subjects with primary lung cancer
• Studying the overall survival from initial diagnosis of lung cancer and from diagnosis of metastases (to various sites)
Chloe Chang Su (Stanford University)
Summer Han (Stanford University)
-
Overall Survival Among Patients With De Novo Stage IV Metastatic and Distant Metastatic Recurrent Non-Small Cell Lung Cancer.
Su CC, Wu JT, Choi E, Myall NJ, Neal JW, Kurian AW, Stehr H, Wood D, Henry SM, Backhus LM, Leung AN, Wakelee HA, Han SS
JAMA Netw Open. 2023 Sep 5; Volume 6 (Issue 9): Pages e2335813 PUBMED -
Impact of Low-Dose Computed Tomography Screening for Primary Lung Cancer on Subsequent Risk of Brain Metastasis.
Su CC, Wu JT, Neal JW, Popat RA, Kurian AW, Backhus LM, Nagpal S, Leung AN, Wakelee HA, Han SS
J Thorac Oncol. 2021 Jun 6 PUBMED